Spring 2026
Startups to watch in 2026
The Spring 2026 issue of European Biotechnology Magazine presents a list of start-ups to watch in 2026 and explores other fascinating topics such as: Can biotechnology finally fix infertility? Can Europe finance and keep its biotech winners? Can gene-silencing transform rare disease research?
Ten young European biotech companies are starting 2026 with great momentum, with the potential to rapidly translate promising scientific findings into meaningful data. This includes initial clinical trials, the transition from platform to pipeline, and substantial funding rounds that can accelerate their implementation. The Spring 2026 issue of European Biotechnology Magazine presents this young companies.
Also in this issue:
- Europe’s distinct biotech venture studio model
- Macroycles: big is the new beautiful
- Is the Unified Patent Court affordable for small biotech?
- Algae cultivation gets easier for biopharma
- Interviews with Alexis Vandier, Global head of Servier Ventures, and Ali Tavassoli, Co-Founder and CSO, Curve Therapeutics
- Association news from SLAS, BIOTECH Austria, ELRIG, yebn
- Events: German Biotech Days 2026, Chemspec Europe 2026
- Focus on Portugal’s biotech industry
- Special: Lab automation + data science
- Special: CDMO Landscape Europe
